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within the iROC trial. This company had no role in the design, implementation or interpretation of the data.
Take Home Message
We analysed recovery after radical cystectomy using multiple domains reflecting mobilisation (steps per day), exercise capacity (chair to stand), disability, HRQOL and health economics.
We found most patients recovered most of their physical capacity by 12 weeks of surgery.
Tweet
Activity trackers help measure recovery after major surgery
Letter
Many patients develop complications after Radical cystectomy (RC) [1] . Reductions in morbidity have occurred through centralization, technical improvements [2] and perhaps through Robot-assisted RC (RARC). Whilst RARC is gaining popularity, there are concerns about oncological safety [3] , extra-corporeal reconstruction [4] and RCTs find little difference [5] . We are conducting a prospective RCT comparing open RC and RARC with mandated intracorporeal reconstruction (iROC [6] ). Within this trial we quantify recovery using multiple domains: personal activity trackers, the 30 second Chair Stand Test (CST30), and qualitative questionnaires of disability (WHODAS 2.0), HRQOL (EORTC QLQ-C30 and QLQ-BLM30 [6] ) and health economics (EQ-5D-5L).
Given that little is known of these tools in this setting, we included an internal analysis when the first 30 patients reached the primary outcome (90 days after RC). This was reached 209 days after the first recruitment and included 28/30 who underwent their allocated RC (supplementary figures, supplementary table 1). The average time to discharge was 11.0 days (st dev. ± 5.7), and following discharge 20/28 (71%) patients visited their GP or A&E, and 5/28 (18%) were readmitted to hospital. Within 90 days of surgery, the average duration out of healthcare was 76.6 ± 6.7 days. Post-operative complications were seen in 15/28 patients, including; Clavien-Dindo Grade 1 in 5/28, Grade 2 in 7/28 and grade 3a/3b in 3/28 (11%, supplementary tables). Baseline compliance varied from 22/28 (79%) for activity trackers, 24/28 (86%) for CST30, 27/28 (96%) for WHODAS 2.0, 27/28 (96%) for QLQ-C30, to 28/28 (100%) for EQ-5D-5L. The observed values (figure 1) matched the general population (e.g. average WHODAS 2.0 score (15%) was within 78% of general population, CTS30 (average 13) was similar to that for >65 year old males and >60 year old females [7] ) or were slightly lower (age matched Canadian men and women walked 7,869 and 6,970/steps per day, respectively [8] ). Compliance with activity trackers and CTS30 improved during recruitment as the trial staff became experienced with collection during the perioperative period.
Each measure deteriorated after surgery (figure 2). At day 5 (POD5) the average number of daily steps was 1840 ± 1348 (32±22% baseline) and CTS30 was 8.3±5.3 (62.0±38% baseline).
Activities levels improved such that by week 5 walking reached 74±32% of the baseline p>0.08). Average daily steps was not correlated to CTS30 (r=-0.08, p=0.7 in 20 patients) and was closest to the QLQ-C30 domain reflecting QOL (r=0.41, p=0.08). In this small sample size, one could hypothesise that daily steps reflect actual activity whilst CTS30 is a measure of lower limb strength and exercise capacity (which may not be used).
In conclusion, we report multi-domain measurements of recovery after RC. Our measures appear well tolerated by patients, are applicable to routine practice, are likely to be useful within our RCT and in the RC pathway. 
